Annual accounts
Micro Entity accounts
28/02/2026Filing deadline
- Next accounts made up to
- 31/05/2025
- Last accounts made up to
- 31/05/2024
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Compulsory strike-off action has been discontinued
First Gazette notice for compulsory strike-off
Second filing of a statement of capital following an allotment of shares on 2025-05-13
Compulsory strike-off action has been discontinued
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Micro Entity accounts
28/02/2026Filing deadline
Confirms the registry record is up to date
The latest figures IMMUNOBIOLOGY LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
2024: £-171.66K
Total Assets
2024: £14.62K
Cash in Bank
2024: £12.87K
Total Liabilities
2024: £186.28K
Employees
2024: 3
Of the 4 measures with an earlier filing to compare against, 3 rose and 1 fell. Net assets moved furthest, up 184.32% on 2024. See the full financial analysis for IMMUNOBIOLOGY LIMITED.
The full financial record
Four ways through IMMUNOBIOLOGY LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 3 | 0 |
| 2024 | 3 | 0 |
| 2023 | 3 | 0 |
| 2022 | 3 | 0 |
| 2021 | 3 | – |
Reported employee count was unchanged at 3 between 2021 and 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 22/01/2001–Present | 10 | |
| Director | 08/09/2006–16/08/2012 | 5 | |
| Director | 06/12/2011–16/08/2012 | 8 | |
| Director | 16/08/2012–Present | 40 | |
| Director | 03/04/2019–Present | 35 | |
| Director | 22/01/2001–24/11/2005 | 11 | |
| Director | 12/12/2003–24/11/2005 | 50 | |
| Director | 12/12/2003–24/11/2005 | 35 | |
| Director | 16/08/2012–17/05/2021 | 20 | |
| Director | 08/09/2006–27/09/2016 | 3 | |
| Director | 16/08/2012–01/06/2020 | 11 | |
| Director | 06/12/2000–17/12/2002 | 9 | |
| Director | 06/02/2004–24/11/2005 | 48 | |
| Director | 26/05/1999–24/11/2005 | 9 | |
| Director | 05/12/2001–24/11/2005 | 0 | |
| Director | 24/11/2005–26/03/2007 | 5 | |
| Director | 13/04/2010–04/04/2020 | 2 | |
| Director | 24/11/2005–06/02/2008 | 0 | |
| Director | 06/02/2008–13/04/2010 | 2 | |
| Secretary | 26/05/1999–15/03/2006 | 1 | |
| Secretary | 15/03/2006–19/03/2020 | 0 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 12/03/2019–Present | 75 |
Every document on the Companies House record, newest first.
Compulsory strike-off action has been discontinued
First Gazette notice for compulsory strike-off
Second filing of a statement of capital following an allotment of shares on 2025-05-13
Compulsory strike-off action has been discontinued
Micro company accounts made up to 2024-05-31
Statement of capital following an allotment of shares on 2025-05-13
Compulsory strike-off action has been suspended
First Gazette notice for compulsory strike-off
Confirmation statement made on 2025-02-27 with updates
Confirmation statement made on 2024-04-26 with updates
Compulsory strike-off action has been discontinued
Unaudited abridged accounts made up to 2023-05-31
Showing 12 of 16 filings
See when the next accounts and confirmation statement are due
111 UK companies are similar to IMMUNOBIOLOGY LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
Alison Business Centre, 39-40 Alison Crescent, Sheffield S2 1AS
Unit 3 Clipstone Brook Industrial Estate, Cherrycourt Way, Leighton Buzzard LU7 4GP
Linlarrock Rockbourne Road, Rockbourne, Fordingbridge, Dorset SP6 3NT
Unit 17 Avonbank Industrial Centre, West Town Road, Bristol BS11 9DE
6th Floor One London Wall, London EC2Y 5EB
A short description of the company, written from its Companies House record.
IMMUNOBIOLOGY LIMITED is a private limited company registered in the United Kingdom, based in 2 Communications Road, Greenham Business Park, Newbury, Berkshire RG19 6AB. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 27 years 3 months.
The register currently records it as active. Its 2025 accounts report net assets of £144.74K and 3 employees. Its accounts are past the filing deadline shown on the registry record.
Answered from this company's own registry record and filed figures.
Companies House records IMMUNOBIOLOGY LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
IMMUNOBIOLOGY LIMITED is recorded as active on the Companies House register, and has been on it since 26/05/1999.
The most recent accounts Okredo holds cover 2025 and report net assets of £144.74K, total assets of £155.62K, cash in bank of £155.62K and total liabilities of £10.88K.
The most recent document on the record is dated 09/05/2026: Compulsory strike-off action has been discontinued, 4 months ago.
On the current registry record, accounts are due by 28/02/2026, which has passed.
Companies House lists 21 officers (3 currently in post) and 1 person with significant control.